Mendessi Oumaima, Daoud Bilel, Nouri Omar, Mnejja Wafa, Sahnoun Tarek, Daoud Jamel, Farhat Leila
Higher Institute of Medical Technology of Tunis, University of Tunis El Manar I, Tunis, Tunisia; Medical Physics Unit, Radiotherapy Department, University Hospital Habib-Bourguiba, Sfax, Tunisia.
Department of Imaging Physics Research, MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
Cancer Radiother. 2025 Jul;29(4):104645. doi: 10.1016/j.canrad.2025.104645. Epub 2025 Jun 23.
With the advancement of radiotherapy techniques for nasopharyngeal carcinoma, it is essential to evaluate the comparative effectiveness of volumetric-modulated arc therapy and intensity-modulated radiotherapy. This study aimed to evaluate the dosimetric and radiobiological differences between the two techniques for the treatment of nasopharyngeal carcinomas.
This retrospective study involved replanning of 125 cases of nasopharyngeal carcinoma using both intensity-modulated radiotherapy and volumetric-modulated arc therapy techniques. Dosimetric evaluation was performed using dose-volume histogram parameters, while radiobiological analysis was conducted using normal tissue complication probability models. Target coverage (dose delivered to 95 % of the high-risk planning target volume), mean dose, and maximum dose to organs at risk, as well as normal tissue complication probability values, were compared between the two techniques.
Both intensity-modulated radiotherapy and volumetric-modulated arc therapy provided comparable dosimetric outcomes. Volumetric-modulated arc therapy showed advantages in certain parameters, with a higher dose delivered to 95 % of the high-risk planning target volume and lower maximum dose for the right and left optic nerves, chiasma, and lenses. Conversely, intensity-modulated radiotherapy provided better sparing of the parotid glands, resulting in lower normal tissue complication probability values. The larynx, pharynx, and thyroid also received lower mean doses with intensity-modulated radiotherapy. The results remained consistent in subgroups of both early and advanced stages of nasopharyngeal carcinoma.
Intensity-modulated radiotherapy and volumetric-modulated arc therapy both have distinct advantages in treating nasopharyngeal carcinoma. Organs at risk protected vary between the two techniques. The radiobiological parameters, including normal tissue complication probability models and dosimetric measures, highlight the differential benefits of each technique.
随着鼻咽癌放射治疗技术的进步,评估容积调强弧形放疗和调强放疗的相对有效性至关重要。本研究旨在评估这两种技术在治疗鼻咽癌时的剂量学和放射生物学差异。
这项回顾性研究涉及对125例鼻咽癌病例分别使用调强放疗和容积调强弧形放疗技术进行重新计划。使用剂量体积直方图参数进行剂量学评估,同时使用正常组织并发症概率模型进行放射生物学分析。比较了两种技术的靶区覆盖情况(给予高危计划靶体积95%的剂量)、平均剂量、危及器官的最大剂量以及正常组织并发症概率值。
调强放疗和容积调强弧形放疗的剂量学结果相当。容积调强弧形放疗在某些参数上具有优势,给予高危计划靶体积95%的剂量更高,右侧和左侧视神经、视交叉和晶状体的最大剂量更低。相反,调强放疗对腮腺的保护更好,导致正常组织并发症概率值更低。调强放疗时喉、咽和甲状腺也接受较低的平均剂量。在鼻咽癌早期和晚期亚组中结果均保持一致。
调强放疗和容积调强弧形放疗在治疗鼻咽癌方面都有明显优势。两种技术对危及器官的保护有所不同。包括正常组织并发症概率模型和剂量学测量在内的放射生物学参数突出了每种技术的不同益处。